1. Home
  2. CHMI vs ALXO Comparison

CHMI vs ALXO Comparison

Compare CHMI & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cherry Hill Mortgage Investment Corporation

CHMI

Cherry Hill Mortgage Investment Corporation

HOLD

Current Price

$2.62

Market Cap

83.3M

Sector

Real Estate

ML Signal

HOLD

Logo ALX Oncology Holdings Inc.

ALXO

ALX Oncology Holdings Inc.

HOLD

Current Price

$2.23

Market Cap

68.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHMI
ALXO
Founded
2012
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.3M
68.3M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
CHMI
ALXO
Price
$2.62
$2.23
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$3.00
$3.42
AVG Volume (30 Days)
177.5K
760.3K
Earning Date
03-05-2026
03-05-2026
Dividend Yield
15.44%
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$40,202,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$31.73
N/A
P/E Ratio
$138.24
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.17
$0.40
52 Week High
$3.68
$2.62

Technical Indicators

Market Signals
Indicator
CHMI
ALXO
Relative Strength Index (RSI) 44.23 73.43
Support Level $2.54 $2.23
Resistance Level $2.63 $2.62
Average True Range (ATR) 0.06 0.28
MACD -0.02 0.08
Stochastic Oscillator 12.00 87.30

Price Performance

Historical Comparison
CHMI
ALXO

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: